Jump to content

18802972. FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF (Novartis AG)

From WikiPatents

FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF

Organization Name

Novartis AG

Inventor(s)

Salvatore Bongarzone of Loranze IT

Davide Camporese of Saint Genis Pouilly FR

Gonçalo dos Santos Clemente of Basel Stadt CH

Takeru Ehara of Tokyo JP

Matteo Fischer of Basel CH

Andrei Alexandrovich Golosov of Medford MA US

Philipp Grosche of Inzlingen DE

Philipp Holzer of Sissach CH

Alexei Karpov of Basel CH

Marion Lacaud-baumlin of Geispitzen FR

Lukas Leder of Biel-Benken CH

Rafael Bermeo Malo of Basel CH

Andreas Marzinzik of Weil am Rhein DE

Yoshihide Mizukoshi of Kanagawa-shi JP

Charlie Munsch of Blotzheim FR

Markus Oliver Reschke of Birsfelden CH

Holger Sellner of Buchs CH

Therese-Marie Stachyra of Mulhouse FR

FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF

This abstract first appeared for US patent application 18802972 titled 'FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF

Original Abstract Submitted

Described herein are cyclic peptides targeting fibroblast activation protein (FAP), and their incorporation into compounds for radioligand imaging and therapies, as well as methods and/or uses of such compounds for the imaging, treatment and/or prevention of FAP-implicated diseases and disorders.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.